Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock
CYCCP
CYCCP
0 hedge funds and large institutions have $0 invested in Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| – | – | -10 | Closed |
|
|
2
UBS Group
Zurich,
Switzerland
| – | – | -6 | Closed |
|
|
CFGS
3
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|